Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
7.35
+0.42 (6.06%)
Nov 21, 2024, 1:09 PM EST - Market open

Silence Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
344672547715611-
Upgrade
Market Cap Growth
135.77%22.71%-23.44%17.04%--
Upgrade
Enterprise Value
152600448612549-
Upgrade
Last Close Price
6.9317.3715.2523.8922.00-
Upgrade
PS Ratio
14.0620.7825.9642.5381.67-
Upgrade
PB Ratio
2.5830.9320.5861.9349.39-
Upgrade
P/TBV Ratio
7.3259.0833.06580.25487.96-
Upgrade
P/FCF Ratio
---96.09--
Upgrade
P/OCF Ratio
---77.58--
Upgrade
EV/Sales Ratio
6.9618.5721.2336.4073.34-
Upgrade
EV/FCF Ratio
---82.24--
Upgrade
Debt / Equity Ratio
0.000.020.020.020.040.01
Upgrade
Debt / FCF Ratio
---0.02-0.17
Upgrade
Asset Turnover
0.120.250.170.140.080.01
Upgrade
Quick Ratio
8.614.104.035.412.773.84
Upgrade
Current Ratio
9.314.564.415.692.993.88
Upgrade
Return on Equity (ROE)
-102.80%-221.19%-264.65%-448.22%-217.21%-69.98%
Upgrade
Return on Assets (ROA)
-27.27%-30.80%-29.82%-31.44%-29.33%-33.45%
Upgrade
Return on Capital (ROIC)
-63.40%-155.63%-194.80%-317.04%-126.58%-50.52%
Upgrade
Earnings Yield
-25.05%-8.20%-8.91%-7.46%-7.27%-
Upgrade
FCF Yield
-7.47%-10.04%1.04%-2.52%-
Upgrade
Buyback Yield / Dilution
-21.50%-15.21%-8.58%-8.78%-8.85%-6.85%
Upgrade
Total Shareholder Return
-21.50%-15.21%-8.58%-8.78%-8.85%-6.85%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.